Home | Business News | CBJ Newsmakers | Tetra Bio-Pharma to Present Key Research Findings as Part of Food and Drug Administration (FDA) Public Hearing on CBD Tetra Bio-Pharma to Present Key Research Findings as Part of Food and Drug Administration (FDA) Public Hearing on CBD RecommendedAustralia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory ChangeParex Resources Announces 12 Consecutive Years of Reserves Per Share Growth, a 50% Increase to the Regular Dividend and Provides 2023 Guidance UpdateSandfire Resources America AnnouncesĀ Change of Auditor
